Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Brill, S.
Right arrow Articles by di Vadi, P. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brill, S.
Right arrow Articles by di Vadi, P. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2002, Vol. 89, No. 5 711-714
© 2002 The Board of Management and Trustees of the British Journal of Anaesthesia

Clinical Investigations

Efficacy of intravenous magnesium in neuropathic pain

S. Brill1, P. M. Sedgwick2, W. Hamann1,3 and P. P. di Vadi*,1

1 Department of Anaesthetics and Pain Management, University Hospital Lewisham, Lewisham High Street, London SE13 6LH, UK. 2 Department of Public Health Sciences, St George’s Hospital Medical School, London SW17 ORE, UK. 3 GKT School of Medicine, Pain Management Unit, Guy’s and St Thomas’ Hospital, London SE1 9RT, UK *Corresponding author

Background. Postherpetic neuralgia is a complication of acute herpes zoster characterized by severe pain and paraesthesia in the skin area affected by the initial infection. There is evidence that the N-methyl-D-aspartate receptor is involved in the development of hypersensitivity states and it is known that magnesium blocks the N-methyl-D-aspartate receptor.

Method. A double-blind, placebo-controlled, cross-over study was conducted in which magnesium sulphate was administered as an i.v. infusion. Spontaneous pain was recorded and qualitative sensory testing with cotton wool was performed in seven patients with postherpetic neuralgia before and after the i.v. administration of either magnesium sulphate 30 mg kg–1 or saline.

Results. During the administration, pain scores were significantly lower for magnesium compared with placebo at 20 and 30 min (P=0.016) but not at 10 min. I.V. magnesium sulphate was safe, well-tolerated and effective in patients with postherpetic neuralgia.

Conclusion. The present study supports the concept that the N-methyl-D-aspartate receptor is involved in the control of postherpetic neuralgia.

Br J Anaesth 2002; 89: 711–14


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Br J AnaesthHome page
C. Y. Lin, P. S. Tsai, Y. C. Hung, and C. J. Huang
L-type calcium channels are involved in mediating the anti-inflammatory effects of magnesium sulphate
Br. J. Anaesth., November 20, 2009; (2009) aep336v1.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
M. F. M. James
Magnesium: an emerging drug in anaesthesia
Br. J. Anaesth., October 1, 2009; 103(4): 465 - 467.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
C. Lysakowski, L. Dumont, C. Czarnetzki, and M. R. Tramer
Magnesium as an Adjuvant to Postoperative Analgesia: A Systematic Review of Randomized Trials
Anesth. Analg., June 1, 2007; 104(6): 1532 - 1539.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
V. Jaitly and P. P. di Vadi
Efficacy of intravenous magnesium in neuropathic pain
Br. J. Anaesth., August 1, 2003; 91(2): 302 - 302.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.